Skip to main content
SpringerLink
Log in

Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Background

The homeobox (HOX) genes have been implicated playing important roles in many human cancers. HOXA13 is a member of HOX genes that encode transcription factors regulating embryonic development and cell fate. In the present study, we aimed to investigate the expression and prognostic significance of HOXA13 in bladder cancer.

Methods

Immunohistochemical staining was initially performed to screen the differentially expressed HOXA13 between bladder cancer tissues and paired adjacent non-cancerous tissues. Subsequent Western blotting analysis validation was conducted using tissue samples from patients with bladder cancer.

Results

The expression level of HOXA13 was significantly higher in bladder cancer tissues compared to that in adjacent non-cancerous tissues (P < 0.001). The χ2-test showed that expression of HOXA13 was positively correlated with lymphatic metastasis (P = 0.013), bladder tumor TNM stage (P = 0.002) and pathological grade (P < 0.001). Kaplan-Meier survival analysis revealed that patients with bladder cancer with high expression of HOXA13 had shorter overall survival time (P = 0.001) and disease-free survival time (P = 0.001) compared to patients with low expression of HOXA13. Multivariate analysis indicated that HOXA13 was an independent prognostic factor for overall survival for bladder cancer patients.

Conclusions

The results of our study show that high expression of HOXA13 is associated with the progression of bladder cancer and that HOXA13 might serve as a biomarker for prognosis of bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;66(1):1059–73.

    Article  Google Scholar 

  2. Seifert A, Werheid DF, Knapp SM, Tobiasch E. Role of Hox genes in stem cell differentiation. World J Stem Cells. 2015;7(3):583–95.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Javed S, Langley SE. Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection. BJU Int. 2014;113(4):535–40.

    Article  CAS  PubMed  Google Scholar 

  4. Cantile M, Franco R, Schiavo G, Procino A, Cindolo L, Botti G, et al. The HOX genes network in uro-genital cancers: mechanisms and potential therapeutic implications. Curr Med Chem. 2011;18(32):4872–84.

    Article  CAS  PubMed  Google Scholar 

  5. Acampora D, D’Esposito M, Faiella A, Pannese M, Migliaccio E, Morelli F, et al. The human HOX gene family. Nucleic Acids Res. 1989;17(24):10385–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Burke AC, Nelson CE, Morgan BA, Tabin C. Hox genes and the evolution of vertebrate axial morphology. Development. 1995;121(2):333–46.

    CAS  PubMed  Google Scholar 

  7. Duboule D. The vertebrate limb: a model system to study the Hox/HOM gene network during development and evolution. Bioessays. 1992;14(6):375–84.

    Article  CAS  PubMed  Google Scholar 

  8. Maroulakou IG, Spyropoulos DD. The study of HOX gene function in hematopoietic, breast and lung carcinogenesis. Anticancer Res. 2003;23(3A):2101–10.

    CAS  PubMed  Google Scholar 

  9. De Vita G, Barba P, Odartchenko N, Givel JC, Freschi G, Bucciarelli G, et al. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer. 1993;29A(6):887–93.

    Article  PubMed  Google Scholar 

  10. Cantile M, Scognamiglio G, La Sala L, La Mantia E, Scaramuzza V, Valentino E, et al. Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers. Int J Mol Sci. 2013;14(11):21727–40.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1574–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, et al. The HOX gene network in hepatocellular carcinoma. Int J Cancer. 2014;129(11):2577–87.

    Article  Google Scholar 

  13. Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A, Pandha HS. Targeting HOX transcription factors in prostate cancer. BMC Urol. 2014;14:17.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Scott V, Morgan EA, Stadler HS. Genitourinary functions of Hoxa13 and Hoxd13. J Biochem. 2005;137(6):671–6.

    Article  CAS  PubMed  Google Scholar 

  15. Pan TT, Jia WD, Yao QY, Sun QK, Ren WH, Huang M, et al. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma. Tohoku J Exp Med. 2014;234(3):209–19.

    Article  PubMed  Google Scholar 

  16. Han Y, Tu WW, Wen YG, Li DP, Qiu GQ, Tang HM, et al. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry. Med Oncol. 2013;30(2):564.

    Article  PubMed  Google Scholar 

  17. Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med. 2015;13:84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Duan R, Han L, Wang Q, Wei J, Chen L, Zhang J, et al. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways. Oncotarget. 2015;6(29):27778–93.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ma RL, Shen LY, Chen KN. Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma. Oncol Rep. 2014;31(5):2157–64.

    CAS  PubMed  Google Scholar 

  20. Guo B, Che T, Shi B, Guo L, Zhang Z, Li L, et al. Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer. Int J Clin Exp Med. 2015;8(3):3619–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Guo B, Che T, Shi B, Guo L, Yin Y, Li L, et al. Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray. Can Urol Assoc J. 2011;5(6):E129–37.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Holyoake A, O’Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, et al. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clin Cancer Res. 2008;14(3):742–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 300016, Hangzhou, Zhejiang, China

    Haiyi Hu, Yuebing Chen, Sheng Cheng, Gonghui Li & Zhigen Zhang

Authors
  1. Haiyi Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuebing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sheng Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gonghui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhigen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuebing Chen.

Ethics declarations

Conflict of interest

H. Haiyi, C. Yuebing, C. Sheng, L. Gonghui, and Z. Zhigen declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, H., Chen, Y., Cheng, S. et al. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer. Wien Klin Wochenschr 129, 391–397 (2017). https://doi.org/10.1007/s00508-016-1108-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-016-1108-4

Keywords

Search

Navigation